Loading…
Secreted phospholipase A 2 modifies extracellular vesicles and accelerates B cell lymphoma
Extracellular vesicles (EVs) including exosomes act as intercellular communicators by transferring protein and microRNA cargoes, yet the role of EV lipids remains unclear. Here, we show that the pro-tumorigenic action of lymphoma-derived EVs is augmented via secreted phospholipase A (sPLA )-driven l...
Saved in:
Published in: | Cell metabolism 2022-04, Vol.34 (4), p.615 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 4 |
container_start_page | 615 |
container_title | Cell metabolism |
container_volume | 34 |
creator | Kudo, Kai Miki, Yoshimi Carreras, Joaquim Nakayama, Shunya Nakamoto, Yasushi Ito, Masatoshi Nagashima, Etsuko Yamamoto, Kei Higuchi, Hiroshi Morita, Shin-Ya Inoue, Asuka Aoki, Junken Ando, Kiyoshi Nakamura, Naoya Murakami, Makoto Kotani, Ai |
description | Extracellular vesicles (EVs) including exosomes act as intercellular communicators by transferring protein and microRNA cargoes, yet the role of EV lipids remains unclear. Here, we show that the pro-tumorigenic action of lymphoma-derived EVs is augmented via secreted phospholipase A
(sPLA
)-driven lipid metabolism. Hydrolysis of EV phospholipids by group X sPLA
, which was induced in macrophages of Epstein-Barr virus (EBV) lymphoma, increased the production of fatty acids, lysophospholipids, and their metabolites. sPLA
-treated EVs were smaller and self-aggregated, showed better uptake, and increased cytokine expression and lipid mediator signaling in tumor-associated macrophages. Pharmacological inhibition of endogenous sPLA
suppressed lymphoma growth in EBV-infected humanized mice, while treatment with sPLA
-modified EVs reversed this phenotype. Furthermore, sPLA
expression in human large B cell lymphomas inversely correlated with patient survival. Overall, the sPLA
-mediated EV modification promotes tumor development, highlighting a non-canonical mechanistic action of EVs as an extracellular hydrolytic platform of sPLA
. |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_35294862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>35294862</sourcerecordid><originalsourceid>FETCH-pubmed_primary_352948623</originalsourceid><addsrcrecordid>eNqFjs0KwjAQhIMgtv68guwLFGpSqz2qKN715KWszRYjiQ1JK_btjaBnD8MwH8MwAxYvCsGTVcbTiI29v6epyEUhRiwSS15k65zH7HKiylFLEuyt8UFaWfQEG-BgGqlqRR7o1TqsSOtOo4MneVXpgPEhAavAyWEb8hY-HdC9CTsGp2xYo_Y0-_qEzQ_78-6Y2O5qSJbWKYOuL39nxN_CG4oNQEI</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Secreted phospholipase A 2 modifies extracellular vesicles and accelerates B cell lymphoma</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Kudo, Kai ; Miki, Yoshimi ; Carreras, Joaquim ; Nakayama, Shunya ; Nakamoto, Yasushi ; Ito, Masatoshi ; Nagashima, Etsuko ; Yamamoto, Kei ; Higuchi, Hiroshi ; Morita, Shin-Ya ; Inoue, Asuka ; Aoki, Junken ; Ando, Kiyoshi ; Nakamura, Naoya ; Murakami, Makoto ; Kotani, Ai</creator><creatorcontrib>Kudo, Kai ; Miki, Yoshimi ; Carreras, Joaquim ; Nakayama, Shunya ; Nakamoto, Yasushi ; Ito, Masatoshi ; Nagashima, Etsuko ; Yamamoto, Kei ; Higuchi, Hiroshi ; Morita, Shin-Ya ; Inoue, Asuka ; Aoki, Junken ; Ando, Kiyoshi ; Nakamura, Naoya ; Murakami, Makoto ; Kotani, Ai</creatorcontrib><description>Extracellular vesicles (EVs) including exosomes act as intercellular communicators by transferring protein and microRNA cargoes, yet the role of EV lipids remains unclear. Here, we show that the pro-tumorigenic action of lymphoma-derived EVs is augmented via secreted phospholipase A
(sPLA
)-driven lipid metabolism. Hydrolysis of EV phospholipids by group X sPLA
, which was induced in macrophages of Epstein-Barr virus (EBV) lymphoma, increased the production of fatty acids, lysophospholipids, and their metabolites. sPLA
-treated EVs were smaller and self-aggregated, showed better uptake, and increased cytokine expression and lipid mediator signaling in tumor-associated macrophages. Pharmacological inhibition of endogenous sPLA
suppressed lymphoma growth in EBV-infected humanized mice, while treatment with sPLA
-modified EVs reversed this phenotype. Furthermore, sPLA
expression in human large B cell lymphomas inversely correlated with patient survival. Overall, the sPLA
-mediated EV modification promotes tumor development, highlighting a non-canonical mechanistic action of EVs as an extracellular hydrolytic platform of sPLA
.</description><identifier>EISSN: 1932-7420</identifier><identifier>PMID: 35294862</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Epstein-Barr Virus Infections ; Extracellular Vesicles ; Herpesvirus 4, Human ; Humans ; Lymphoma ; Lymphoma, B-Cell ; Mice ; Phospholipases A2, Secretory</subject><ispartof>Cell metabolism, 2022-04, Vol.34 (4), p.615</ispartof><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35294862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kudo, Kai</creatorcontrib><creatorcontrib>Miki, Yoshimi</creatorcontrib><creatorcontrib>Carreras, Joaquim</creatorcontrib><creatorcontrib>Nakayama, Shunya</creatorcontrib><creatorcontrib>Nakamoto, Yasushi</creatorcontrib><creatorcontrib>Ito, Masatoshi</creatorcontrib><creatorcontrib>Nagashima, Etsuko</creatorcontrib><creatorcontrib>Yamamoto, Kei</creatorcontrib><creatorcontrib>Higuchi, Hiroshi</creatorcontrib><creatorcontrib>Morita, Shin-Ya</creatorcontrib><creatorcontrib>Inoue, Asuka</creatorcontrib><creatorcontrib>Aoki, Junken</creatorcontrib><creatorcontrib>Ando, Kiyoshi</creatorcontrib><creatorcontrib>Nakamura, Naoya</creatorcontrib><creatorcontrib>Murakami, Makoto</creatorcontrib><creatorcontrib>Kotani, Ai</creatorcontrib><title>Secreted phospholipase A 2 modifies extracellular vesicles and accelerates B cell lymphoma</title><title>Cell metabolism</title><addtitle>Cell Metab</addtitle><description>Extracellular vesicles (EVs) including exosomes act as intercellular communicators by transferring protein and microRNA cargoes, yet the role of EV lipids remains unclear. Here, we show that the pro-tumorigenic action of lymphoma-derived EVs is augmented via secreted phospholipase A
(sPLA
)-driven lipid metabolism. Hydrolysis of EV phospholipids by group X sPLA
, which was induced in macrophages of Epstein-Barr virus (EBV) lymphoma, increased the production of fatty acids, lysophospholipids, and their metabolites. sPLA
-treated EVs were smaller and self-aggregated, showed better uptake, and increased cytokine expression and lipid mediator signaling in tumor-associated macrophages. Pharmacological inhibition of endogenous sPLA
suppressed lymphoma growth in EBV-infected humanized mice, while treatment with sPLA
-modified EVs reversed this phenotype. Furthermore, sPLA
expression in human large B cell lymphomas inversely correlated with patient survival. Overall, the sPLA
-mediated EV modification promotes tumor development, highlighting a non-canonical mechanistic action of EVs as an extracellular hydrolytic platform of sPLA
.</description><subject>Animals</subject><subject>Epstein-Barr Virus Infections</subject><subject>Extracellular Vesicles</subject><subject>Herpesvirus 4, Human</subject><subject>Humans</subject><subject>Lymphoma</subject><subject>Lymphoma, B-Cell</subject><subject>Mice</subject><subject>Phospholipases A2, Secretory</subject><issn>1932-7420</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFjs0KwjAQhIMgtv68guwLFGpSqz2qKN715KWszRYjiQ1JK_btjaBnD8MwH8MwAxYvCsGTVcbTiI29v6epyEUhRiwSS15k65zH7HKiylFLEuyt8UFaWfQEG-BgGqlqRR7o1TqsSOtOo4MneVXpgPEhAavAyWEb8hY-HdC9CTsGp2xYo_Y0-_qEzQ_78-6Y2O5qSJbWKYOuL39nxN_CG4oNQEI</recordid><startdate>20220405</startdate><enddate>20220405</enddate><creator>Kudo, Kai</creator><creator>Miki, Yoshimi</creator><creator>Carreras, Joaquim</creator><creator>Nakayama, Shunya</creator><creator>Nakamoto, Yasushi</creator><creator>Ito, Masatoshi</creator><creator>Nagashima, Etsuko</creator><creator>Yamamoto, Kei</creator><creator>Higuchi, Hiroshi</creator><creator>Morita, Shin-Ya</creator><creator>Inoue, Asuka</creator><creator>Aoki, Junken</creator><creator>Ando, Kiyoshi</creator><creator>Nakamura, Naoya</creator><creator>Murakami, Makoto</creator><creator>Kotani, Ai</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20220405</creationdate><title>Secreted phospholipase A 2 modifies extracellular vesicles and accelerates B cell lymphoma</title><author>Kudo, Kai ; Miki, Yoshimi ; Carreras, Joaquim ; Nakayama, Shunya ; Nakamoto, Yasushi ; Ito, Masatoshi ; Nagashima, Etsuko ; Yamamoto, Kei ; Higuchi, Hiroshi ; Morita, Shin-Ya ; Inoue, Asuka ; Aoki, Junken ; Ando, Kiyoshi ; Nakamura, Naoya ; Murakami, Makoto ; Kotani, Ai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_352948623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Epstein-Barr Virus Infections</topic><topic>Extracellular Vesicles</topic><topic>Herpesvirus 4, Human</topic><topic>Humans</topic><topic>Lymphoma</topic><topic>Lymphoma, B-Cell</topic><topic>Mice</topic><topic>Phospholipases A2, Secretory</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kudo, Kai</creatorcontrib><creatorcontrib>Miki, Yoshimi</creatorcontrib><creatorcontrib>Carreras, Joaquim</creatorcontrib><creatorcontrib>Nakayama, Shunya</creatorcontrib><creatorcontrib>Nakamoto, Yasushi</creatorcontrib><creatorcontrib>Ito, Masatoshi</creatorcontrib><creatorcontrib>Nagashima, Etsuko</creatorcontrib><creatorcontrib>Yamamoto, Kei</creatorcontrib><creatorcontrib>Higuchi, Hiroshi</creatorcontrib><creatorcontrib>Morita, Shin-Ya</creatorcontrib><creatorcontrib>Inoue, Asuka</creatorcontrib><creatorcontrib>Aoki, Junken</creatorcontrib><creatorcontrib>Ando, Kiyoshi</creatorcontrib><creatorcontrib>Nakamura, Naoya</creatorcontrib><creatorcontrib>Murakami, Makoto</creatorcontrib><creatorcontrib>Kotani, Ai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cell metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kudo, Kai</au><au>Miki, Yoshimi</au><au>Carreras, Joaquim</au><au>Nakayama, Shunya</au><au>Nakamoto, Yasushi</au><au>Ito, Masatoshi</au><au>Nagashima, Etsuko</au><au>Yamamoto, Kei</au><au>Higuchi, Hiroshi</au><au>Morita, Shin-Ya</au><au>Inoue, Asuka</au><au>Aoki, Junken</au><au>Ando, Kiyoshi</au><au>Nakamura, Naoya</au><au>Murakami, Makoto</au><au>Kotani, Ai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secreted phospholipase A 2 modifies extracellular vesicles and accelerates B cell lymphoma</atitle><jtitle>Cell metabolism</jtitle><addtitle>Cell Metab</addtitle><date>2022-04-05</date><risdate>2022</risdate><volume>34</volume><issue>4</issue><spage>615</spage><pages>615-</pages><eissn>1932-7420</eissn><abstract>Extracellular vesicles (EVs) including exosomes act as intercellular communicators by transferring protein and microRNA cargoes, yet the role of EV lipids remains unclear. Here, we show that the pro-tumorigenic action of lymphoma-derived EVs is augmented via secreted phospholipase A
(sPLA
)-driven lipid metabolism. Hydrolysis of EV phospholipids by group X sPLA
, which was induced in macrophages of Epstein-Barr virus (EBV) lymphoma, increased the production of fatty acids, lysophospholipids, and their metabolites. sPLA
-treated EVs were smaller and self-aggregated, showed better uptake, and increased cytokine expression and lipid mediator signaling in tumor-associated macrophages. Pharmacological inhibition of endogenous sPLA
suppressed lymphoma growth in EBV-infected humanized mice, while treatment with sPLA
-modified EVs reversed this phenotype. Furthermore, sPLA
expression in human large B cell lymphomas inversely correlated with patient survival. Overall, the sPLA
-mediated EV modification promotes tumor development, highlighting a non-canonical mechanistic action of EVs as an extracellular hydrolytic platform of sPLA
.</abstract><cop>United States</cop><pmid>35294862</pmid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1932-7420 |
ispartof | Cell metabolism, 2022-04, Vol.34 (4), p.615 |
issn | 1932-7420 |
language | eng |
recordid | cdi_pubmed_primary_35294862 |
source | BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS |
subjects | Animals Epstein-Barr Virus Infections Extracellular Vesicles Herpesvirus 4, Human Humans Lymphoma Lymphoma, B-Cell Mice Phospholipases A2, Secretory |
title | Secreted phospholipase A 2 modifies extracellular vesicles and accelerates B cell lymphoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secreted%20phospholipase%20A%202%20modifies%20extracellular%20vesicles%20and%20accelerates%20B%20cell%20lymphoma&rft.jtitle=Cell%20metabolism&rft.au=Kudo,%20Kai&rft.date=2022-04-05&rft.volume=34&rft.issue=4&rft.spage=615&rft.pages=615-&rft.eissn=1932-7420&rft_id=info:doi/&rft_dat=%3Cpubmed%3E35294862%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-pubmed_primary_352948623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/35294862&rfr_iscdi=true |